An Open Trial of Metacognitive Remediation Therapy and Pharmacotherapy to Promote Smoking Cessation among Individuals with Psychotic-Spectrum Disorders

Table 5

Smoking-related outcomes.

Measure	(%)
At least one quit attempt during study period	38 (79.2%)
Confirmed abstinence (per CO levels and self-report)
8 weeks	3 (6.3%)
13 weeks	2 (4.2%)
Smoking reduction
8 weeks	11 (22.9%)
13 weeks	9 (18.8%)
CO levels
Baseline	26.90
8 weeks	22.83
13 weeks	25.59